期刊文献+

乳腺癌间质T细胞亚群与乳腺癌5年生存率相关性的研究

Relationship between Tumor Infiltrating T Cell Subsets and the 5-year-survival Rate of Patients with Breast Cancer
在线阅读 下载PDF
导出
摘要 目的研究乳腺癌间质T细胞亚群与患者5 a生存率及临床病理特征的关系。方法采用免疫组化方法检测80例乳腺浸润性导管癌间质中CD4+、CD8+T细胞和Foxp3+调节性T细胞(Foxp3+Treg)的表达。结果乳腺癌间质中T细胞亚群的表达与患者5 a生存率无相关性(P>0.05);乳腺癌间质中Foxp3+Treg的浸润与pTNM分期、组织学分级、淋巴结转移呈正相关(P<0.05),与年龄、肿瘤大小无显著性差异(P>0.05);乳腺癌间质中CD4+和CD8+T细胞的浸润与pTNM分期、组织学分级、淋巴结转移呈负相关(P<0.05),与年龄、肿瘤大小无显著性差异(P>0.05)。结论乳腺癌间质Foxp3+T细胞可抑制CD4+和CD8+T细胞的表达,打破肿瘤间质免疫平衡状态,对癌细胞免疫逃逸和肿瘤的侵袭、转移有积极作用。 Objective To analyze the relationship between tumor infiltrating T cell subsets with the 5- year-survival rate and clinicopathologieal features of the patients with breast cancer. Methods The expression of CD4 +, CD8 + T cells and Foxp3 + regulatory T cells (Foxp3 + Treg) were detected by immunohistochemistry in 80 cases of breast carcinoma. Results There were no correlation between the expression of tumor infiltrating T cell subsets and the 5-year-survival rate of the patients with breast cancer(P 〉 0.05 ). Tumor infiltrating Foxp3 + Tregs in the breast cancer mesenchyma was positively correlated to lymph node metastasis, histological grading, pTNM staging (P 〈 0.05 ) , and had no correlation with age and the diameter of tumor. Tumor infiltrating CD4 + T and CD8 + T cells were negatively correlated to lymph node metastasis, histological grading, pTNM staging(P 〈 0.05) , and had no correlation with age and the diameter of tumor. Conclusion Tumor infiltrating Foxp3 + Tregs in the breast cancer mesenchyma can inhibit the expression of CD4 + and CD8 + T cells, alter the immune equilibrium of breast cancer stromal, and contribute to tumor invasion.
出处 《河南科技大学学报(医学版)》 2013年第1期12-15,共4页 Journal of Henan University of Science & Technology:Medical Science
关键词 乳腺癌 间质T细胞亚群 5 a生存率 breast cancer tumor infiltrating T cell subset 5-year-survival rate
  • 相关文献

参考文献10

  • 1Zltlne HD. Immunology [ M ]. Philadelphia : WB Saunders Co,2001,35(7) :129 - 135.
  • 2奚桂林,于益芝.CD4^+CD25^+调节性T细胞研究进展[J].国外医学(免疫学分册),2004,27(3):141-145. 被引量:18
  • 3Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein scurfin results in the lymphoproliferative disorder of the scurfy mouse [ J ]. Nat Genet, 2001, 27(1):68-73.
  • 4Beyer M. Regulatory T cells in cancer [ J ]. Blood,2006,, 108 (3): 804 - 811.
  • 5Nishikawa H, Kato T, Tawara I, generation/activation of CD4 antitumor immune response[ J]. - 4440. et al. IFN-gamma controls the CD25 regulatory T cells in Immune ,2005,175 ( 7 ) :4433.
  • 6Liyanage Uk, Moore TT,Joo HG, et al. Prevalence of regulatory T ceils is increased in peripheral blood and tumor microenviroment of patients with pancreas or breastadenocarcinomal [ J]. J Immunal,2002,169(5 ) :2756 - 2761.
  • 7Sakaguchi S, Yamaguchi T , Nomura T, et al. Regulatory T cells and immune tolerance [ J ]. Ce11,2008,133:775 - 787.
  • 8Cao X, Cai SF, Fehniger TA, et al . Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance [ J]. Immunity , 2007, 27:635 - 646.
  • 9何生,巴明臣,章崇杰,魏大鹏,赵宗荣.肿瘤浸润淋巴细胞及重组白细胞介素2治疗原发性肝细胞癌[J].中国普通外科杂志,1999,8(2):85-88. 被引量:3
  • 10Sutmuller RP, Van LM, Duivenvoorde A, et al. Synergism of cytotoxic T Lymphocyte-associated antigen 4 blockade and depletion of CD25 + Regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T Lymphocyte response[J ], J Exp Med, 2001,194 (6) :823 -829.

二级参考文献23

  • 1王一,陈汉,吴孟超,宝建中,丛文铭,王皓,张秀忠.肝癌肿瘤浸润淋巴细胞的研究与应用[J].中华外科杂志,1995,33(1):29-31. 被引量:16
  • 2顾琴龙,王天翔,尹浩然,林言箴.肿瘤浸润淋巴细胞治疗消化道肿瘤的初步探讨[J].中国实用外科杂志,1995,15(12):730-733. 被引量:6
  • 3姚德茂 潘承恩 等.肿瘤浸润性淋巴细胞.重组白细胞介素-Ⅱ治疗对术后复发性肝癌病人细胞免疫功能的影响[J].中华实验外科杂志,1995,12(5):257-258.
  • 4Piccirillo CA,Letterio JJ,Thornton AM,et al.CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.[J].J Exp Med,2002,196(2):237-246.
  • 5Sakaguchi S,Sakaguchi N,Shimizu J,et al.Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells:their common role in controlling autoimmunity,tumor immunity,and transplantation tolerance.[J].Immunol Rev,2001,182:18-32.
  • 6Sakaguchi S,Sakaguchi N,Shimizu J,et al.Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells:their common role in controlling autoimmunity,tumor immunity,and transplantation tolerance.[J].Immunol Rev,2001,182:18-32.
  • 7Almeida AR,Legrand N,Papiernik M,Freitas AA.Homeostasis of peripheral CD4+ T cells:IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers.[J].J Immunol,2002,169(9):4850-4860.
  • 8Wood KJ,Sakaguchi S.Regulatory T cells in transplantation tolerance.[J].Nat Rev Immunol,2003,3(3):199-210.
  • 9Bach JF.Protective role of infections and vaccinations on autoimmune diseases.[J].N Engl J Med,2002,347(12):911-920.
  • 10Shevach EM.CD4+ CD25+ suppressor T cells:more questions than answers.[J].Nature Rev Immunol,2002,2(6):389-400.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部